Contraceptive process and kit for female mammals, comprising a combination of gestagen and oestrogen
US6995149B1 · kind B1 · utility
63Cited by
10References
64Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 20, 1996 |
| Grant date | Feb 7, 2006 |
| Priority date | — |
| Expiry date | Dec 20, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P15/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a female mammal contraceptive process consisting of the sequential administration for at least 28 days of (a) a gestagen in an ovulation-preventing dose for at least 28 days in combination with (b) a natural oestrogen for 5 to 10 days at the end of the sequential dosage of at least 28 days, and a contraception kit.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.